Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11000520
Buprenorphine dosing regimens
granted -
US 11000562
Use of isolated fractions of mastic gum for treating optic neuropathy
granted -
US 11000493
Solid solution compositions and use in chronic inflammation
granted -
US 11000570
Isoform Nell-1 peptide
granted -
US 11000502
Antimicrobial compositions comprising copper-hydroxypyrone complexes
granted -
US 11000409
Devices and methods for slurry generation
granted -
US 2021128573
DOSING REGIMENS FOR USE IN TREATING MYELOFIBROSIS AND MPN-RELATED DISORDERS WITH NAVITOCLAX
granted -
US 10993936
Method of treating one or more symptoms of pulmonary fibrosis by administering inhibitors of nicotinamide phosphoribotransferase
granted -
US 10995156
Acid-degradable and bioerodible modified polyhydroxylated materials
granted -
US 10994014
Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors
granted -
US 10993959
Methods and compositions for increasing the suppressive function of regulatory T-cells (Tregs)
granted -
US 10993948
RNA polymerase I inhibitors and uses thereof
granted -
US 10993419
Genetically modified cells, tissues, and organs for treating disease
granted -
US 10995100
Bicyclic heterocyclyl derivatives as IRAK4 inhibitors
granted -
US 10995061
SPAK kinase inhibitors as neuroprotective agents
granted -
US 10995071
Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide
granted -
US 10995336
Serpina1 iRNA compositions and methods of use thereof
granted -
US 10995317
NK cells exhibiting an adaptive phenotype and methods for preparing and for using
granted -
US 10995150
Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody
granted -
US 10995328
Materials and methods for treatment of autosomal dominant cone-rod dystrophy
granted -
US 10995146
Methods of treating severe insulin resistance by interfering with glucagon receptor signaling
granted -
US 10995087
Crystal form of URAT1 inhibitor, and preparation method therefor
granted -
US 10995068
Synthetic sphingolipid-like molecules, drugs, methods of their synthesis and methods of treatment
granted -
US 10995335
RNAi agents and compositions for inhibiting expression of angiopoietin-like 3 (ANGPTL3), and methods of use
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.